Relating to the use, possession, delivery, or manufacture of testing equipment that identifies the presence of a substance listed in Penalty Group 1-B or xylazine.
Relating to human trafficking prevention, including training for first responders, disclosure of human trafficking information by certain health care facilities, and protection for facility employees who report human trafficking.
Relating to notice provided by a chemical dependency treatment facility to the parent, managing conservator, or guardian of a minor refused admission to the facility.